Stem Cell Sciences Plc (SCS), which provides researchers with stem cell culture media, said its revenue from ordinary activities declined by 20% to £593,000 in 2007 from £742,000 in 2006 while its operating loss from ordinary activities rose to £3,572,000 from £2,608,000.
